Best AI Avatar Tools 2026: HeyGen vs Tavus vs Synthesia

This ranking reflects GraiLogic’s own scores for AI avatar tools, checked August 21, 2026. Each score is provisional, built from named public reviews, and measures how a tool stacks up against the strongest option in the category today, where 100 is the ceiling. These numbers are early data and may move as we gather more sources. Below, we walk through the six tools in score order, then close with guidance on who fits where.

1. HeyGen — 79/100 (Provisional)

HeyGen tops our current list. Pricing starts at $29/mo on the Creator plan, or $24/mo if billed annually, and there’s a free plan for testing before you commit. Commercial use is tied to paid plans, and an API is available for teams that want to build avatar generation into their own workflows. For creators comparing cost against capability, HeyGen’s combination of a usable free tier and a relatively low paid entry point is a straightforward starting point.

2. Tavus — 78/100 (Provisional)

Tavus sits just behind HeyGen at 78/100. Its pricing model is different from the rest of this list: plans start at $59/mo for the Starter tier, which includes 100 CVI minutes and 3 replicas, while the free tier is capped at 25 conversational minutes. An API is available. Commercial use terms are not recorded in our data, so creators planning to sell or publish work made with Tavus should confirm licensing directly with the company before relying on it for client work.

3. Synthesia — 75/100 (Provisional)

Synthesia scores 75/100. The entry point is $29/mo on the Starter plan, with a free Basic tier offering 10 minutes a month, watermarked. Annual billing brings meaningful savings — roughly $18/mo for Starter and $64/mo for the Creator tier. Commercial use is confirmed on paid plans, and an API is available, making Synthesia a reasonable option for teams that need both scale and clarity on usage rights.

4. DeepBrain AI Studios — 62/100 (Provisional)

DeepBrain AI Studios ranks fourth at 62/100. Pricing starts at $24/mo on the Personal plan, which includes 60 credits per month (720 per year if billed annually). A free tier is available. Commercial use terms are not recorded, and API availability is not recorded either, so anyone needing programmatic access or firm commercial licensing will need to check directly with the vendor before building a workflow around it.

5. Hour One — 61/100 (Provisional)

Hour One scores 61/100. Its Lite plan runs $25/mo billed annually or $30/mo month to month, and a free tier is available for evaluation. As with DeepBrain, commercial use is not recorded in our data, and API availability is not recorded. Creators drawn to Hour One’s pricing should treat both of those gaps as open questions to resolve before committing budget to a project with commercial stakes.

6. Akool — 58/100 (Provisional)

Akool is sixth on our list at 58/100. The Starter tier is free but limited to 720p, 5-minute outputs with a watermark. The Pro tier runs $21-30/mo monthly, or $18-21/mo billed annually. An API is available, which is a point in its favor for developers, but commercial use terms are not recorded, so the same caution applies here as with Tavus, DeepBrain, and Hour One.

How the tools compare

Who should pick what

Creators who want the strongest overall score today, with confirmed commercial rights on a paid plan, should start with HeyGen or Synthesia. Both name commercial use as tied to paid plans, both include an API, and both have workable free tiers to test output quality before paying.

If your workflow depends on conversational or interactive avatar minutes rather than standard video generation, Tavus scores close behind HeyGen, but the higher entry price and unconfirmed commercial use terms mean it’s worth a direct conversation with the vendor before scaling a paid project on top of it.

Budget-conscious creators exploring lower tiers should look at DeepBrain AI Studios, Hour One, or Akool, all of which offer entry prices near or below $30/mo and free tiers for testing. None of these three have confirmed commercial use terms in our data, and API access is either unavailable or unrecorded for two of them, so they suit experimentation and internal use more comfortably than they suit client-facing commercial deliverables until licensing is clarified.